ArticleCurrent research in toxicology2025
Novel dose- and time-dependent toxicity biomarkers of fentanyl/carfentanyl: uncovered by urine-plasma metabolomics for forensics.
Article in Current research in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fentanyl analogs present a significant global risk to public health and safety due to their high abuse potential and related mortality. However, the absence of a structured research framework focused on their clinical pharmacology and toxicology has led to a scarcity of studies on the mechanisms underlying the toxicity of and addiction to these substances, particularly regarding the rapidly emerging new fentanyl analogs. In this study, we employed a nontargeted metabolomics strategy. By conducting multivariate statistical analysis on ultrahigh performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) data from rat urine and plasma to elucidate the metabolic disruptions induced by fentanyl and carfentanyl. Adult male SD rats were randomly assigned to four groups: low-dose fentanyl group, high-dose fentanyl group, low-dose carfentanyl group, and high-dose carfentanyl group. All groups underwent continuous tail vein injection of toxicants for 5 consecutive days. Plasma and urine samples were collected from the rats before the first administration and at different time points after the last administration, followed by detection and analysis. Specifically, we aimed to elucidate the dose- and time-dependent metabolic toxicity of fentanyl and carfentanyl through a nontargeted metabolomics strategy. Oxidative stress, immunosuppression, and energy dysregulation were identified as core toxic effects of fentanyl and carfentanyl, tightly linked to perturbations in taurine and glutathione pathways, taurine regulating immune function and neuronal homeostasis, glutathione maintaining redox homeostasis. Succinic acid and taurine were confirmed as common biomarkers in urine and plasma. Succinic acid showed decreased plasma levels and increased urine levels, directly indicating fentanyl and carfentanyl-induced energy metabolism impairment. Taurine exhibited similar dysregulation, reflecting drug-induced immunosuppression and neuronal excitability abnormalities. These findings provide critical references and experimental support for studies on fentanyl-related hazards, toxicological mechanisms, and forensic detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.